Carey reveals the troubling tactics used by a major chemical company to manipulate public perception of glyphosate's safety. Internal communications expose a strategy of ghostwriting scientific papers and op-eds, misleading regulators and the public for decades. The discussion highlights the stark contrast between independent scientific findings and the orchestrated defense of glyphosate, raising critical questions about corporate accountability and public health.
